Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 5,701 | 5,285 | 52,860 | 3,608 | 3,829 |
| Cost of Goods | 1,209 | 998 | 724 | 569 | 306 |
| Gross Profit | 4,492 | 4,287 | 52,136 | 3,039 | 3,523 |
| Operating Expenses | 12,785 | -19,013 | 8,931 | 13,021 | 15,105 |
| Operating Income | -8,084 | 24,298 | 43,929 | -9,413 | -11,276 |
| Other Income | 803 | 769 | 638 | 456 | 410 |
| Pre-tax Income | -7,281 | 25,067 | 44,567 | -8,957 | -10,866 |
| Income Tax | N/A | 341 | 248 | 3 | N/A |
| Net Income Continuous | -7,281 | 24,726 | 44,319 | -8,960 | -10,866 |
| Net Income | $-7,281 | $24,726 | $44,319 | $-8,960 | $-10,866 |
| EPS Basic Total Ops | -0.64 | 2.36 | 3.72 | -0.80 | -1.04 |
| EPS Basic Continuous Ops | -0.61 | 2.37 | 3.72 | -0.78 | -1.03 |
| EPS Diluted Total Ops | -0.64 | 2.36 | 3.68 | -0.80 | -1.04 |
| EPS Diluted Continuous Ops | -0.61 | 2.35 | 3.71 | -0.78 | -1.03 |
| EBITDA(a) | $-7,869 | $24,476 | $44,147 | $-9,170 | $-11,050 |